Piribo logo
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report offering a detailed guide on how to conduct effective deal making in drug delivery.
“Effective Deal Making in Drug Delivery”, available at http://tinyurl.com/
Effective deal making is particularly important in the present economic climate. A marked loss of confidence in equity markets has continued to weaken public share offerings such that they are not currently viewed as an attractive means of raising the money that is required for rapid growth of drug delivery companies. Indeed, following the burst of the technology bubble in 2001 and the subsequent drop of market indices, 2006 and 2007 showed some slow recovery. By the second half of 2008, the biotech/pharma IPO window has completely shut down and markets have dropped dramatically.
As a result there has been even more pressure on dealmakers to strike the right deals and strategic alliances to fuel growth. The rapid rise in the number and value of deals shows the increasing reliance upon the development of strategic alliances for gaining access to innovation and the funds that are required for product development and corporate expansion.
The report begins with an assessment of the current and evolving drug delivery market, drug delivery companies and the challenges that are facing the drug delivery sector. The key driving factors that underlie the drug delivery sector are considered, including improving the therapeutic index of drugs, patient benefit and compliance, increasing the length of patent protection and product life cycle management. The report also reviews the business strategies that are employed for the commercialisation of drug delivery systems and an in-depth analysis addresses drug delivery alliances and their financial terms. Further, the report examines the drug delivery deal making activity of the top 10 pharmaceutical companies by healthcare sales, to help the reader understand the partnering activities of the largest healthcare companies. The valuation methodologies used when formulating deal terms are also described.
The drug delivery sector represents a dynamic, rapidly evolving sector as companies vie for partnering positions that will maximise commercial returns. Both market needs and technology innovation continue to drive this special sector, and it will be interesting to witness its evolution over the ensuing years.
“Effective Deal Making in Drug Delivery” is available from Piribo. For further information, please visit:
http://www.piribo.com/
Piribo product ID: PVT00018
Photo:
http://www.prlog.org/
